Option Care Health (OPCH) director receives $200,000 RSU grant and fee-based units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Deckmann Natasha reported acquisition or exercise transactions in this Form 4 filing.

Option Care Health, Inc. director Natasha Deckmann reported two equity awards of common stock on May 20, 2026. She received 8,997 restricted stock units that vest in full on May 20, 2027, granted in lieu of cash retainer payments. She also received an additional award of 844 restricted stock units, calculated to reflect $200,000 of value based on the closing share price on the grant date, which will also vest fully on May 20, 2027.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Deckmann Natasha

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,997	$0.00	--
Grant/Award	Common Stock	844	$22.23	$19K

Holdings After Transaction: Common Stock — 31,158 shares (Direct, null)

Footnotes (1)

The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Key Figures

RSU grant value: $200,000 RSUs granted (comp award): 844 shares Grant price reference: $22.23 per share +2 more

5 metrics

RSU grant value $200,000 Restricted stock unit award sized to value on May 20, 2026

RSUs granted (comp award) 844 shares Common stock restricted stock units granted on May 20, 2026

Grant price reference $22.23 per share Price used in Form 4 for 844-share RSU grant

RSUs in lieu of cash fees 8,997 shares Restricted stock units granted instead of cash retainer on May 20, 2026

RSU vesting date May 20, 2027 Full vesting date for both RSU awards

Key Terms

restricted stock units, cash retainer payments, closing price, common stock

4 terms

restricted stock units financial

"The reporting person received an award of restricted stock units on May 20, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

cash retainer payments financial

"received restricted stock units on May 20, 2026 in lieu of cash retainer payments"

closing price financial

"calculated to reflect $200,000 of value based on the closing price of the issuer's common stock"

common stock financial

"based on the closing price of the issuer's common stock on May 20, 2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 06:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Deckmann Natasha

(Last)

(First)

(Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN

ILLINOIS

60015

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/20/2026		A		8,997⁽¹⁾	A	$0	31,158	D
Common Stock	05/20/2026		A		844⁽²⁾	A	$22.23	32,002	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

2. The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

	/s/ Michael Bavaro, attorney-in-fact for Ms. Deckmann	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Natasha Deckmann report in her latest Form 4 for OPCH?

Natasha Deckmann reported two equity awards of Option Care Health common stock. She received 8,997 restricted stock units and a separate award of 844 restricted stock units, both granted on May 20, 2026 and scheduled to vest fully on May 20, 2027.

How many Option Care Health (OPCH) restricted stock units did Deckmann receive?

Deckmann received two grants totaling 8,997 and 844 restricted stock units, respectively. Both awards were granted on May 20, 2026 as compensation, with each grant scheduled to vest in full on May 20, 2027 according to the disclosed terms.

What is the value of Natasha Deckmann’s new equity award at Option Care Health (OPCH)?

One of Deckmann’s restricted stock unit awards was explicitly sized to reflect $200,000 of value. The number of units in that grant was determined using the closing price of Option Care Health’s common stock on May 20, 2026, the grant date.

Why did Natasha Deckmann receive restricted stock units instead of cash from OPCH?

Deckmann received restricted stock units in lieu of cash retainer payments. The filing explains that the number of units was calculated to match the amount of cash fees taken in stock, using the closing price of Option Care Health’s shares on May 20, 2026.

When do Natasha Deckmann’s new Option Care Health (OPCH) RSU awards vest?

Both restricted stock unit awards granted to Deckmann on May 20, 2026 vest in full on May 20, 2027. This one-year vesting schedule applies to the $200,000 value-based grant and the separate grant made in lieu of cash retainer fees.